Price to Book Value Chart

View Price to Book Value for GPCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2023. Start Trial.
Date Value
August 24, 2026 2.577
August 21, 2026 2.581
August 20, 2026 2.656
August 19, 2026 2.846
August 18, 2026 2.815
August 17, 2026 2.827
August 14, 2026 2.866
August 13, 2026 2.876
August 12, 2026 2.835
August 11, 2026 2.741
August 10, 2026 2.829
August 07, 2026 2.794
August 06, 2026 2.767
August 05, 2026 2.657
August 04, 2026 2.610
August 03, 2026 2.543
July 31, 2026 2.526
July 30, 2026 2.601
July 29, 2026 2.490
July 28, 2026 2.518
July 27, 2026 2.560
July 24, 2026 2.583
July 23, 2026 2.671
July 22, 2026 2.651
July 21, 2026 2.595
Date Value
July 20, 2026 2.470
July 17, 2026 2.549
July 16, 2026 2.420
July 15, 2026 2.609
July 14, 2026 2.660
July 13, 2026 2.715
July 10, 2026 2.806
July 09, 2026 2.899
July 08, 2026 2.886
July 07, 2026 2.978
July 06, 2026 2.879
July 02, 2026 2.810
July 01, 2026 2.740
June 30, 2026 2.822
June 29, 2026 2.538
June 26, 2026 2.441
June 25, 2026 2.370
June 24, 2026 2.365
June 23, 2026 2.240
June 22, 2026 2.235
June 18, 2026 2.186
June 17, 2026 2.21
June 16, 2026 2.107
June 15, 2026 2.115
June 12, 2026 2.108

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Eli Lilly & Co. 35.06
Novo Nordisk A/S 6.308
Pfizer Inc. 1.905
Tarsus Pharmaceuticals, Inc. 9.015
Johnson & Johnson 7.755

Price to Book Value Related Metrics

Price 49.97
Earnings Yield -6.16%
Market Cap 3.559B